CelThera™ Stem34 Differentiation Medium AOF

CelThera™ Stem34 Differentiation Medium AOF is a chemically defined, animal origin-free medium specifically designed for the efficient differentiation of human pluripotent stem cells (PSCs) into hematopoietic stem/progenitor cells (HSPCs), and to support subsequent multilineage differentiation of HSPCs, including NK cells, megakaryocyte/platelet lineages, and other hematopoietic lineages. Engineered to address key challenges in hematopoietic differentiation, including consistency, efficiency, and scalability, it provides a robust and streamlined platform for iPSC-HSPC multilineage differentiation workflows.

With the same formulation and raw materials across RUO and GMP grades, CelThera™ Stem34 Differentiation Medium AOF enables a seamless transition from research to clinical development while minimizing process changes and revalidation efforts. Standardized manufacturing, stringent quality control, and comprehensive raw-material traceability ensure high batch-to-batch consistency and regulatory readiness.

*Note: This product is optimized for PSC-to-HSPC differentiation and subsequent multilineage differentiation. For applications requiring dedicated HSPC expansion, a specialized HSPC expansion medium is currently under development.

• Seamless RUO-to-GMP Transition: Consistent formulation and core raw materials support smooth process transition from research to clinical development.
• High Batch-to-Batch Consistency: Standardized manufacturing and stringent quality control ensure excellent batch-to-batch consistency and performance.
• End-to-End Hematopoietic Workflow: Supports iPSC-to-HSC multilineage differentiation workflows, including T/NK and megakaryocyte/platelet lineages, with complementary cytokines such as SCF, TPO, and FLT3L available as a one-stop solution.
• Animal-Origin-Free & Regulatory-Friendly: AOF formulation and comprehensive raw-material traceability support research and translational applications.
• Cost-Effective & Scalable: Optimized formulation and scalable manufacturing help improve process efficiency and control overall manufacturing costs.

CelThera™ Stem34 Differentiation Medium AOF is stable for 24 months when stored at -20°C.

This product is supplied and shipped with dry ice, please inquire the shipping cost.